Company
Unlearn
Driving clarity in clinical development
Also known as Unlearn AI, Unlearn.ai, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- top pharma and biotechs
- Legal name
- Unlearn.ai, Inc.
- unlearn.ai (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At Unlearn, we are defining the future of clinical development with unmatched scientific credibility, replacing uncertainty with AI-powered precision so decisions are clearer and trials are stronger.
Funding snapshot
- Total raised
- $115MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $50M2024-01-25
Funding rounds
- Round, 2024
- $50M2024-01-25, SEC form D sold, 9 investors
- Round, 2022
- $50M2022-04-05, SEC form D sold, 14 investors
- Round, 2020
- $15M2020-04-03, SEC form D sold, 11 investors
Products
- Web
- scientific intelligence layer for clinical development
Loading relationship preview